Quality Assurance

Biotech holding company announces facilities GMP-certified for drug production

Published in AIDS Weekly, November 7th, 2005

Nutra Pharma Corp. (NPHC) has announced its minority holding, ReceptoPharm, Inc., has been GMP-qualified (Good Manufacturing Practices) to manufacture drugs for human clinical trials in the European Union (E.U.).

ReceptoPharm had invited an audit earlier this year in order to identify areas of potential weakness prior to initiating the production of their lead drug products to supply upcoming clinical trials. The E.U. drug production standards are higher than that of the U.S. Food and Drug Administration (FDA), making it essential to have lab certification for support of a clinical trial application. Though not required, the company plans to invite local FDA inspectors...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2005-11-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry